Загрузка...
Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease
BACKGROUND: Three classes of inhaler medication are used to manage chronic obstructive pulmonary disease (COPD): long‐acting beta₂‐agonists (LABA); long‐acting muscarinic antagonists (LAMA); and inhaled corticosteroids (ICS). To encourage patient adherence, two classes of medication are often combin...
Сохранить в:
| Опубликовано в: : | Cochrane Database Syst Rev |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2018
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513478/ https://ncbi.nlm.nih.gov/pubmed/30141826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012355.pub2 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|